BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Why Gilead Should Keep an Eye on Juno’s New CAR-T Strategy

  CAR-T is a hot new area and there are companies hot on Gilead’s tail, namely Juno, in a partnership with Celgene, and Novartis.

  November 17, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Takeda CEO Actively Hunts for Deals, Looks to Shed Non-Core Businesses

  Bloomberg noted that Takeda’s CEO is looking at making Takeda a nimble company, but one with a deeply entrenched R&D focus.

  November 17, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Biotech Beach

  Why San Diego’s NuVasive Could be a Hidden Gem

  Hidden gems are long-term market beaters that have market caps below $10 billion and brand names most people won’t recognize.

  November 17, 2017

   · 

  1 min read
• Genetown

  ZIOPHARM Oncology to Host Conference Call on November 20, 2017 at 10:15 a.m. ET to Discuss Updated Clinical Data Presented at the 2017 Annual Meeting of the Society for Neuro-Oncology

  Call to feature key neuro-oncology thought leaders.

  November 17, 2017

   · 

  2 min read
• 

  Deals

  Cambridge Biotech Quartet Medicine to Shut Down by Year End

  The company’s demise was explained in a blog post by Atlas Venture partner Bruce Booth.

  November 17, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Genetown

  SEC Filings Reveal GlaxoSmithKline’s 13% Stake in This Massachusetts Biotech

  A filing with the SEC indicates that Glaxo now has a 13 percent stake in Spero Therapeutics.

  November 17, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Bay

  How Celgene Could Reap Huge Rewards From This Tiny Biotech

  Todd Campbell, writing for The Motley Fool, looks at one of Celgene’s collaborations with a smaller company.

  November 17, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Eli Lilly Insulin Drug Price Tripled While Trump’s HHS Nominee Was President of the U.S. Unit

  Azar, the new HHS nominee, is being pitched as someone who will help lower the price of prescription drugs.

  November 17, 2017

   · 

  1 min read
• 

  Business

  Meet the 6 Powerful Bay Area Biotech VCs You’ve Never Heard About

  A look at six bay area-based VCs who are creating a lot of value in biotech.

  November 17, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  ImmunoCellular Therapeutics to Report Third Quarter 2017 Financial Results on November 21, 2017

  The Company also plans to hold a conference call and webcast on that day at 5:00 pm ET to discuss the third quarter 2017 financial results and provide a business update.

  November 17, 2017

   · 

  1 min read